FDA Approves Immunotherapy for mNSCLC Patients in Study Conducted at Florida Cancer Specialists & Research Institute
Recent FDA Approval of Advanced Treatment for Patients with Metastatic Non Small-Cell Lung Cancer (NSCLC) Demonstrates Importance of Participation in Clinical Trials
December 06, 2022 15:41 ET | Florida Cancer Specialists & Research Institute
Ft. Myers, Fla., Dec. 06, 2022 (GLOBE NEWSWIRE) -- A clinical study conducted with participation by Florida Cancer Specialists & Research Institute, LLC (FCS) has led to FDA approval of a new...